About OrthoLazer

OrthoLazer utilizes MLS M8 Robotic Laser Therapy, an FDA-cleared, non-invasive treatment that emits specific wavelengths of light to reduce pain and inflammation in musculoskeletal conditions. This technology provides an opioid-free solution for individuals suffering from chronic and acute pain, enhancing recovery times and improving quality of life.

```xml <problem> Musculoskeletal pain, whether chronic or acute, often requires pain management solutions. Opioid-based treatments carry risks of addiction and side effects, while traditional therapies may not provide sufficient relief or accelerate recovery effectively. </problem> <solution> OrthoLazer offers MLS M8 Robotic Laser Therapy, a non-invasive, FDA-cleared treatment that utilizes specific wavelengths of light to alleviate pain and inflammation associated with musculoskeletal conditions. The robotic laser technology delivers light energy to damaged cells, stimulating intracellular activity, reducing pain, and accelerating recovery times. This approach provides an opioid-free alternative for individuals seeking relief from conditions such as arthritis, soft tissue injuries, and post-surgical pain. The treatment is automated and designed to deliver consistent and safe dosages of light energy. </solution> <features> - MLS M8 Robotic Laser Therapy: Emits specific wavelengths of light to reduce pain and inflammation. - Non-invasive treatment: Provides pain relief without surgery or injections. - Opioid-free solution: Offers an alternative to opioid-based pain management. - Automated system: Delivers consistent and safe dosages of light energy. - Treats various conditions: Effective for arthritis, soft tissue injuries, and post-surgical pain. </features> <target_audience> The primary target audience includes individuals suffering from chronic or acute musculoskeletal pain, athletes recovering from injuries, and patients seeking post-surgical pain relief. </target_audience> ```

What does OrthoLazer do?

Where is OrthoLazer located?

OrthoLazer is based in Rochester, United States.

When was OrthoLazer founded?

OrthoLazer was founded in 2018.

How much funding has OrthoLazer raised?

OrthoLazer has raised 7000000.

Location

Rochester, United States

Founded

2018

Funding

7000000

Employees

59 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

OrthoLazer

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

ortholazer.com 2K+

Crunchbase

Founded 2018 – Rochester, United States

Funding

Estimated Funding

$5M+

Team (50+)

No team information available.

Company Description

Problem

Musculoskeletal pain, whether chronic or acute, often requires pain management solutions. Opioid-based treatments carry risks of addiction and side effects, while traditional therapies may not provide sufficient relief or accelerate recovery effectively.

Solution

OrthoLazer offers MLS M8 Robotic Laser Therapy, a non-invasive, FDA-cleared treatment that utilizes specific wavelengths of light to alleviate pain and inflammation associated with musculoskeletal conditions. The robotic laser technology delivers light energy to damaged cells, stimulating intracellular activity, reducing pain, and accelerating recovery times. This approach provides an opioid-free alternative for individuals seeking relief from conditions such as arthritis, soft tissue injuries, and post-surgical pain. The treatment is automated and designed to deliver consistent and safe dosages of light energy.

Features

MLS M8 Robotic Laser Therapy: Emits specific wavelengths of light to reduce pain and inflammation.

Non-invasive treatment: Provides pain relief without surgery or injections.

Opioid-free solution: Offers an alternative to opioid-based pain management.

Automated system: Delivers consistent and safe dosages of light energy.

Treats various conditions: Effective for arthritis, soft tissue injuries, and post-surgical pain.

Target Audience

The primary target audience includes individuals suffering from chronic or acute musculoskeletal pain, athletes recovering from injuries, and patients seeking post-surgical pain relief.